This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Digging into the Phase 2 data on Horizon's dazodalibep for Sjögren’s Syndrome

Ticker(s): HZNP, AMGN

Who's the expert?

Institution: University of Pittsburgh Medical Center

  • Assistant Professor of Medicine and Staff Rheumatologist-University of Pittsburgh Medical Center.
  • Manages 180 patients with rheumatoid arthritis, 50 patients with Systemic Lupus Erythematosus
  • Research interests include inflammatory myopathies and  biomarker clinical studies.

Interview Questions
Q1.

Please describe your background and practice setting.

Added By: ben_admin
Q2.

How many patients with Sjögren’s Syndrome do you currently manage?

Added By: ben_admin
Q3.

Are you familiar with the data to date on Dazodalibep?

Added By: ben_admin
Q4.

How impressed were you with the results of the trial?

Added By: ben_admin
Q5.

How do the results compare to the current standard of care?

Added By: ben_admin

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.